| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | VANGUARD INTL EQUITY INDEX F | 1,058,781 | 43,272,000 | 81.83% | ||
| 2 | Anacor Pharmaceuticals Inc | 23,325 | 1,349,000 | 2.55% | ||
| 3 | BIOMARIN | 9,715 | 1,211,000 | 2.29% | ||
| 4 | INCYTE | 12,729 | 1,167,000 | 2.21% | ||
| 5 | BELLICUM PHARMACEUTICALS INC COM | 45,261 | 1,049,000 | 1.98% | ||
| 6 | SEATTLE GENETICS INC | 29,535 | 1,044,000 | 1.97% | ||
| 7 | GENOMIC HEALTH INC COM | 32,167 | 983,000 | 1.86% | ||
| 8 | SYNAGEVA BIOPHARMA CORP | 9,854 | 961,000 | 1.82% | ||
| 9 | ACADIA PHARMACEUTICALS INC COM | 29,356 | 957,000 | 1.81% | ||
| 10 | BIOCRYST PHARMACEUTICALS | 98,161 | 886,000 | 1.68% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001377635-15-000003, filed 2015.05.15).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
